{"id":"W2572398654","doi":"10.1016/s2213-8587(17)30013-x","title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":707,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"","keywords":"Semaglutide; Medicine; Placebo; Tolerability; Type 2 diabetes; Randomized controlled trial; Diabetes mellitus; Dulaglutide; Internal medicine; Clinical trial; Adverse effect; Physical therapy; Exenatide; Liraglutide; Endocrinology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006263967,0.000441895,0.001588263,0.000214766,0.0002581246,0.00006645465,0.0004342394,0.0001098587,0.00005583626],"category_scores_gemma":[0.0004508669,0.0002848584,0.0001393831,0.0001255725,0.0004689309,0.0001524025,0.0001770287,0.0003069968,0.00001217069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001218159,"about_ca_system_score_gemma":0.00006588145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003807423,"about_ca_topic_score_gemma":0.00007629458,"domain_scores_codex":[0.9970189,0.0002571714,0.0006306479,0.0005262088,0.000346841,0.001220246],"domain_scores_gemma":[0.9968204,0.001382069,0.0005982825,0.000917996,0.0001564833,0.0001246905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8965141,0.001930227,0.08367867,0.00008319526,0.001913787,0.00001453928,0.0002255047,0.00009544276,0.0000839971,0.0005210682,0.0001998894,0.01473958],"study_design_scores_gemma":[0.9532591,0.004480334,0.03826632,0.0001235226,0.0008152048,2.351241e-7,0.00009189919,0.0007347246,0.0002450987,0.00005016307,0.001664017,0.0002693881],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858009,0.0007097809,0.000003980711,0.002084226,0.0003359207,0.009780827,0.0000226357,0.00006503685,0.001196654],"genre_scores_gemma":[0.9972869,0.00037507,0.0005177815,0.0002203607,0.000240605,0.0008621333,0.0001367599,0.00004765196,0.0003128074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.056745,"threshold_uncertainty_score":0.9999604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03132321637257893,"score_gpt":0.3149938320151195,"score_spread":0.2836706156425406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}